Hematologic Malignancy: Clinical Trials

32 trials for Hematologic Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

32 completed. 32 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable32Completed 32

Follow Hematologic Malignancy: new trials by email Literature Review of Hematologic Malignancy trials Research Report on Hematologic Malignancy

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Home Transfusion for HEME
Home Transfusion Program Components - Hematologic Malignancy
Not applicableCompletedDana-Farber Cancer Institute102024-10-182025-09-25
VitalTraq for the Detection of CRS
TempTraq, VitalTraq - Hematologic Malignancy
Not applicableCompletedDuke University322024-10-132026-07-15
Intervention for Fatigue in HCT Recipients
CBT for Fatigue, Usual Care - Hematologic Cancer, Hematologic Malignancy
Not applicableCompletedMassachusetts General Hospital662023-11-292026-06-05
Telerehabilitation in Hemato-oncological Survivors
Home-based training, Center-based training - Hematologic Malignancy, Lymphoma
Not applicableCompletedBrno University Hospital802023-04-012026-09-30
Survivorship Post-HCT Optimization Program
Exercise training - Hematologic Malignancy
Not applicableCompletedDuke University162022-12-022025-09-26
Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology.
Usual distraction and pain prevention techniques., Virtual reality, Choice between usual distraction or virtual reality - Hematologic Malignancy, Hematologic Non Malignancy
Not applicableCompletedNantes University Hospital342022-06-302024-12-31
Cognitive-behavioural Intervention for Anxiety, Depression and Quality of Life Among Children Receiving Chemotherapy.
Cognitive-behavioural intervention - Hematologic Malignancy, Anxiety
Not applicableCompletedChinese University of Hong Kong762022-04-122023-02-08
Proof-of-Concept Trial of a Positive Psychology Intervention for Caregivers of Patients Undergoing HSCT
Positive Psychology Intervention - Caregiver, Hematologic Malignancy
Not applicableCompletedBrigham and Women's Hospital232022-03-012024-07-01
Positive Psychology Intervention In HSCT
Positive Psychology Intervention - Hematologic Malignancy, Hematopoietic/Lymphoid Cancer
Not applicableCompletedBrigham and Women's Hospital722021-11-172024-07-30
Lighting Intervention for Cancer-related Fatigue
Wearable Sensor, Blue-blocking glasses, Clear glasses - Breast Cancer, Prostate Cancer
Not applicableCompletedUniversity of Michigan Rogel Cancer Center1392021-07-152025-07-09
Removing Transfusion Dependence as a Barrier to Hospice Enrollment
Transfusion support - Hematologic Malignancy, Myelodysplastic Syndromes
Not applicableCompletedAdam Olszewski182021-07-092026-01-15
IIT2020-20-SHIRAZIP-WALK: Nature Walks
Nature based exercise - Breast Cancer, Cancer
Not applicableCompletedCedars-Sinai Medical Center202021-06-212025-02-26
VR for Symptom Control and Wellbeing
Virtual Reality Headset to provide a Virtual Reality Experience - Oncology, End Stage Cancer
Not applicableCompletedRoyal Cornwall Hospitals Trust602021-06-142023-11-21
Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology
TreC-Onco, Paper diary - Cancer, Solid Tumor
Not applicableCompletedIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1242021-05-042025-12-03
Mindfulness and CBT for Sleep
Mindfulness-Based Therapy for Insomnia with Cognitive-Behavioral Symptom Coping Skills - Hematologic Malignancy
Not applicableCompletedDuke University572021-04-012024-12-02
Hospital at Home at EOL in Heme Malignancies
End of Life (EOL) Care at at Home - Hematologic Malignancy
Not applicableCompletedMassachusetts General Hospital722021-02-262026-07-21
Symptom Identification and Management in Patients With Hematological Malignancy During Follow-up Care
HM-PRO - Hematologic Malignancy
Not applicableCompletedCopenhagen University Hospital, Rigshospitalet942021-02-082023-11-28
Effects of NMES and Exercise in Hematological Cancer
Neuromuscular Electrical Stimulation, Structured Exercise - Hematologic Malignancy, Muscle Weakness
Not applicableCompletedAcibadem University312021-02-082022-05-31
A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT
Linac Based VMAT TBI - Hematologic Malignancy
Not applicableCompletedNYU Langone Health362020-09-222026-05-04
Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice
Blood and/or platelet transfusion, Complete blood count (CBC) collection - Hematologic Malignancy
Not applicableCompletedUniversity of Oklahoma202020-08-142024-03-05

Showing 20 of 32. Sign in to see all of them.

Narrower conditions

Hematologic Neoplasms (32)  ·  Neoplasms (5)  ·  Lymphoma (3)  ·  Anxiety Disorders (2)  ·  Breast Neoplasms (2)  ·  Fatigue (2)  ·  Leukemia (2)  ·  Prostatic Neoplasms (2)  ·  Anemia, Sickle Cell (1)  ·  Chronic Disease (1)  ·  Depression (1)  ·  Frailty (1)  ·  Graft vs Host Disease (1)  ·  Hodgkin Disease (1)  ·  Hyperphagia (1)

Broader conditions

Hematologic Diseases (32)  ·  Hemic and Lymphatic Diseases (32)  ·  Neoplasms by Site (32)  ·  Neoplasms (27)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Signs and Symptoms (6)  ·  Immune System Diseases (4)  ·  Immunoproliferative Disorders (4)  ·  Lymphatic Diseases (4)  ·  Lymphoproliferative Disorders (4)  ·  Neoplasms by Histologic Type (4)  ·  Neurologic Manifestations (3)  ·  Pathologic Processes (3)  ·  Behavior (2)  ·  Breast Diseases (2)

Interventions

Amino Acids (1)  ·  Blood Cell Count (1)  ·  Control Groups (1)  ·  Cyclophosphamide (1)  ·  Death Domain (1)  ·  Exercise (1)  ·  Filgrastim (1)  ·  Glucose (1)  ·  High-Intensity Interval Training (1)  ·  Imagery, Psychotherapy (1)  ·  Melphalan (1)  ·  Mesna (1)  ·  Mycophenolic Acid (1)  ·  Platelet Transfusion (1)  ·  Restraint, Physical (1)

Sponsors

Duke University (4)  ·  Massachusetts General Hospital (4)  ·  Brigham and Women's Hospital (3)  ·  Dana-Farber Cancer Institute (3)  ·  Acibadem University (1)  ·  Adam Olszewski (1)  ·  Brno University Hospital (1)  ·  Cedars-Sinai Medical Center (1)  ·  Centre Francois Baclesse (1)  ·  Chinese University of Hong Kong (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS (1)  ·  Kursat Gundogan (1)  ·  Medical College of Wisconsin (1)  ·  Memorial Sloan Kettering Cancer Center (1)

Countries

United States (21)  ·  France (2)  ·  Turkey (Türkiye) (2)  ·  Czechia (1)  ·  Denmark (1)  ·  Ethiopia (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Russia (1)  ·  United Kingdom (1)

Top investigators

Chenyu Lin, MD (2)  ·  Hermioni Amonoo, MD, MPP, MPH (2)  ·  Alessandro Passardi, MD (1)  ·  Alexander Kulagin, Professor (1)  ·  Ant Uzay, MD (1)  ·  Anthony Sung, MD (1)  ·  Arash Asher, M.D. (1)  ·  Areej El-Jawahri, MD (1)  ·  Ashley Nelson, PhD (1)  ·  Brian Shaffer, MD (1)  ·  Celina Shirazipour, PhD (1)  ·  Elif Es Safran, MSc (1)  ·  Fatma Mutluay, Prof (1)  ·  Gregory A. Abel, MD, MPH (1)

Results publications

PMID 34649555, PMID 35017254, PMID 35397575, PMID 35436209, PMID 36027848, PMID 36163030, PMID 37328178, PMID 37442349, PMID 38597262, PMID 39080734, PMID 39828642, PMID 39886490, PMID 39954038, PMID 40056908

NIH funding

K08CA251654 (1), R44CA236557 (1)